Cintas (CTAS) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
3 Feb, 2026Executive summary
Fiscal 2024 revenue reached a record $9.6 billion, up 8.9% year-over-year, with Q4 revenue at $2.47 billion, up 8.2%.
Organic growth for the year was 8%, with Q4 organic growth at 7.5%.
Net income for fiscal 2024 increased 16.6% to $1.57 billion; Q4 net income rose 19.7% to $414.3 million.
Diluted EPS for fiscal 2024 was $15.15, up 16.6%; Q4 diluted EPS was $3.99, up 19.8%.
Cash flow from operations exceeded $2 billion for the first time, supporting $530.9 million in dividends and $1 billion in share repurchases.
Financial highlights
Fiscal 2024 gross margin was 48.8%, up from 47.3% in 2023; Q4 gross margin reached 49.2%.
Fiscal 2024 operating income rose 14.8% to $2.07 billion; Q4 operating income was $547.6 million, up 16.3%.
Fiscal 2024 operating margin reached an all-time high of 21.6%; Q4 operating margin was 22.2%.
Net income margin improved to 16.4% for fiscal 2024 from 15.3% in 2023.
Quarterly dividend increased by 17.4%, marking 40 consecutive years of increases.
Outlook and guidance
Fiscal 2025 revenue expected between $10.16 billion and $10.31 billion, growth of 5.9%-7.4%.
Organic growth for 2025 projected at 6.4%-8%, adjusting for two fewer workdays.
Diluted EPS guidance for 2025 is $16.25-$16.75, up 7.3%-10.6%.
Net interest expense expected to rise to $106 million due to higher variable rate debt.
Fiscal 2025 effective tax rate expected at 20.4%, unchanged from 2024.
Latest events from Cintas
- Record revenue, margin expansion, raised guidance, and UniFirst acquisition highlight strong results.CTAS
Q3 202625 Mar 2026 - $5.5B merger delivers $375M synergies, $310/share for UniFirst, closing in H2 2026.CTAS
M&A announcement11 Mar 2026 - Revenue and profit surged, margins expanded, and guidance was raised for fiscal 2025.CTAS
Q1 202520 Jan 2026 - Directors and key proposals were voted on, with all board and management recommendations approved.CTAS
AGM 202418 Jan 2026 - Revenue and net income surged with margin gains and higher full-year guidance.CTAS
Q2 202510 Jan 2026 - Record revenue, margin expansion, and raised guidance highlight strong quarterly performance.CTAS
Q2 20267 Jan 2026 - Q3 revenue and EPS surged, driving higher guidance and strong margin expansion.CTAS
Q3 20256 Jan 2026 - Directors, executive pay, and auditors approved; special meeting proposal rejected; growth plans highlighted.CTAS
AGM 202514 Dec 2025 - Annual meeting covers director elections, pay, equity plan, auditor, and key ESG shareholder proposals.CTAS
Proxy Filing1 Dec 2025